← SynDRA
GLYX-13
SynDRA canonical compound SYN1949523 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Mechanism of action | glutamate receptor agonist |
|---|
All known targets
- GRIN1
- GRIN2A
- GRIN2B
- GRIN2C
- GRIN2D
- GRIN3A
- GRIN3B
Mechanisms of action (all sources)
- GRIN1 PARTIAL AGONIST
- GRIN2A PARTIAL AGONIST
- GRIN2B PARTIAL AGONIST
- GRIN2D PARTIAL AGONIST
- GRIN3B PARTIAL AGONIST
- GRIN2C PARTIAL AGONIST
- GRIN3A PARTIAL AGONIST
- glutamate receptor agonist
Cross-references
Synonyms
- GLYX 13
- Rapastinel
- GLYX13
- UNII-6A1X56B95E
- L-Threoninamide, L-threonyl-L-prolyl-L-prolyl-
- 6A1X56B95E
- (S)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-1-((S)-1-((2S,3R)-2-amino-3-hydroxybutanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxamide
- GLYX-13 trifluoroacetate
- TPPT-amide trifluoroacetate
- TPPT-amide
- GLYX-13 peptide
- Rapastinel [USAN:INN]
- GLYX13;Rapastinel
- Rapastinel(GLYX-13)
- L-Threonyl-L-prolyl-L-prolyl-L-threoninamide trifluoroacetate
- Thr-Pro-Pro-Thr-NH2 trifluoroacetate
- Rapastinelum
- RefChem:178642
- DTXCID001515565
- MFCD20527320
- RAPASTINEL [INN]
- RAPASTINEL [USAN]
- Rapastinel (GLYX-13)
- Rapastinel(GLYX-13)?
- RAPASTINEL [WHO-DD]
- orb1695663
- SCHEMBL1668190
- EX-A794
- GIBQQARAXHVEGD-BSOLPCOYSA-N
- C18H31N5O6
- MFCD12912477
- s6907
- AKOS024457610
- CS-5507
- NCGC00485669-01
- AC-32874
- AS-55920
- HY-16728
- G4797
- NS00072942
Look up GLYX-13 in the interactive SynDRA portal →